| Title： | EPG Evidence-Based Clinical Practice Guideline for Metabolic Syndrome in children |
| Edition： | Adapted |
| Classification： | Standard guideline |
| Field： | Treatment |
| Countries and regions： | Egypt |
| Guidelines users： | Pediatricians, Pediatric Gastroenterologists, Pediatric Endocrinologists, Clinical Pharmacists, Nurses, Clinical Dietitians at University Hospitals, and Ministry of Health (MOH) Governmental and private hospitals at secondary and tertiary care levels. |
| Evidence classification method： | The 'Formal' Guideline Adaptation Process (Wang et al 2018) followed by the EPG is the 'Adapted ADAPTE' (Amer et al 2015) that includes three phases (set up, adaptation, and finalization). Critical appraisal or quality assessment or evaluation of the eligible source original guidelines is conducted by using the AGREE II Instrument. The rating system for the hierarchy of evidence will follow the same system of the original guideline(s) with their permission. |
| Development unit： | Egyptian Pediatric Clinical Practice Guidelines Committee (EPG) |
| Registration time: | 2023-04-03 |
| Registration number： | PREPARE-2023CN232 |
| Purpose of the guideline: | This CPG aims to produce evidence-based recommendations for the best practice in the diagnosis and treatment of Metabolic Syndrome in children. |
Latest registration
